Signal Genetics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Signal Genetics Inc
CIK #0001590750
EDGAR Form CIK 2011 - 2026
10-K [0001590750]
10-Q [0001590750]
3 [0001590750]
4 [0001590750]
5 [0001590750]
8-K [0001590750]
D [0001590750]
SC 13D [0001590750]
SC 13G [0001590750]
Form 13D/13G Filer Form 13D/13G Subject Filed
Paradigm Biocapital Advisors LP Viridian Therapeutics Inc de [2026-06-26]
Bellevue Group AG Viridian Therapeutics Inc de [2026-05-15]
Deep Track Capital LP Viridian Therapeutics Inc de [2026-05-08]
Kynam Capital Management LP Viridian Therapeutics Inc de [2025-05-15]
Commodore Capital LP Viridian Therapeutics Inc de [2025-04-11]
Perceptive Advisors LLC Viridian Therapeutics Inc de [2024-01-29]
State Street Corp Viridian Therapeutics Inc de [2024-01-24]
FMR LLC Viridian Therapeutics Inc de [2024-01-10]
Venrock Opportunities Fund LP Viridian Therapeutics Inc de [2023-12-08]
Paradigm Biocapital Advisors LP Viridian Therapeutics Inc de [2023-05-11]
Vanguard Group Inc Viridian Therapeutics Inc de [2023-02-09]
BlackRock Inc Viridian Therapeutics Inc de [2023-02-03]
Millennium Management LLC Viridian Therapeutics Inc de [2022-05-31]
Commodore Capital LP Viridian Therapeutics Inc de [2022-05-19]
Paradigm Biocapital Advisors LP Viridian Therapeutics Inc de [2022-02-14]
Avidity Partners Management LP Viridian Therapeutics Inc de [2021-10-28]
Venrock Healthcare Capital Partners III LP Viridian Therapeutics Inc de [2021-10-14]
Vivo Opportunity LLC Viridian Therapeutics Inc de [2021-09-30]
Deep Track Capital LP Viridian Therapeutics Inc de [2021-09-24]
TCG Crossover Management LLC Viridian Therapeutics Inc de [2021-09-10]
Frazier Life Sciences Public Fund LP Viridian Therapeutics Inc de [2021-08-26]
D E Shaw & Co LP Viridian Therapeutics Inc de [2021-05-10]
Wellington Management Group LLP Viridian Therapeutics Inc de [2021-03-10]
Hawkes Bay Master Investors Cayman LP Viridian Therapeutics Inc de [2021-02-19]
Cormorant Asset Management LP Viridian Therapeutics Inc de [2021-01-19]
Citadel Advisors LLC Miragen Therapeutics Inc [2021-01-11]
Xencor Inc Miragen Therapeutics Inc [2021-01-11]
Ally Bridge Medalpha Master Fund LP Miragen Therapeutics Inc [2021-01-07]
Fairmount Funds Management LLC Miragen Therapeutics Inc [2021-01-05]
RA Capital Management LP Miragen Therapeutics Inc [2020-12-17]
Biotechnology Value Fund L P Miragen Therapeutics Inc [2020-11-09]
Logos Global Management LP Miragen Therapeutics Inc [2020-11-09]
Point72 Asset Management LP Miragen Therapeutics Inc [2020-10-29]
683 Capital Partners LP Miragen Therapeutics Inc [2019-01-03]
JAFCO SV4 Investment Limited Partnership Miragen Therapeutics Inc [2017-04-03]
FMR LLC Miragen Therapeutics Inc [2017-03-10]
Boulder Ventures V LP Miragen Therapeutics Inc [2017-02-24]
Atlas Venture Fund VII L P Miragen Therapeutics Inc [2017-02-23]
Remeditex Ventures LLC Miragen Therapeutics Inc [2017-02-17]
Peierls E Jeffrey Signal Genetics Inc [2015-03-20]
Empery Asset Management LP Signal Genetics Inc [2015-02-20]
Heartland Advisors Inc Signal Genetics Inc [2015-02-13]
Lebow 2012 Nevada Trust Signal Genetics Inc [2015-02-11]
LFIT-A Trust Signal Genetics Inc [2015-02-11]
Lebow Alpha LLLP Signal Genetics Inc [2015-02-11]
Form 3/4/5 Subject 2011 - 2026
Miragen Therapeutics Inc
Cain Christopher W
Morris Arlene
Gheuens Sarah
Kiselak Tomas
Ajer Jeffrey Robert
Moses Jennifer K
Fairmount Healthcare Fund II GP LLC
Fairmount Healthcare Fund II LP
Fairmount Funds Management LLC
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Option exercise 5,169
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-03 Option exercise 6,267 $0.00
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Option exercise 9,409
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-03 Option exercise 9,409 $0.00
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Tax withheld 3,138 $29.32 92,006
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Tax withheld 1,724 $29.32 50,548
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Tax withheld 7,627 $29.32 223,624
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Option exercise 18,357
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-03 Option exercise 18,357 $0.00
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Option exercise 6,267
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-03 Option exercise 5,169 $0.00
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Tax withheld 2,091 $29.32 61,308
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
2026-03-02 Grant 176,550 $0.00
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
2026-03-02 Grant 119,300 $0.00
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-02 Grant 23,850 $0.00
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
2026-03-02 Grant 102,850 $0.00
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-02 Grant 20,550 $0.00
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-02 Grant 35,300 $0.00
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-02 Grant 111,900 $0.00
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
2026-03-02 Grant 559,600 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com